China Biotech IPOs Remain In Deep Freeze, Hong Kong Fares Better

 
• By Dexter Jie Yan
  
IPO
China freeze on biopharma IPOs continues, although Hong Kong sees several floats • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia